Abstract:Metastasis is one of the main causes of poor prognosis for hepatocellular carcinoma (HCC), which has been linked to cell-death resistance. Autophagy is an important survival mechanism under conditions of cell stress. We hypothesized that autophagy may play a role in HCC metastasis due to its prosurvival effect. Highly metastatic HCC cell lines with stable autophagy inhibition were established via lentivirus-mediated silencing of BECN1 and ATG5 genes. Mouse models of pulmonary metastasis were then developed using the cells with or without autophagy inhibition. The analysis of lung metastasis by histopathological examination and small animal imaging showed that autophagy inhibition significantly decreased the incidence of pulmonary metastases in vivo. Further invasion, migration, detachment, lung colonization, and epithelial-mesenchymal transition (EMT) assays indicated that autophagy inhibition did not affect cell invasiveness, migration or EMT but attenuated the anoikis-resistance and lung colonization of HCC cells. Investigation of the molecular mechanisms underlying showed that the autophagy-inhibition-mediated anoikis-resistance attenuation was associated with the regulation of apoptotic signaling. As autophagy inhibition was shown to be able to suppress HCC metastasis, an autophagy-based HCC tissue-specific target therapy system (AFP-Cre/LoxP-shRNA) was constructed. In vitro and in vivo analyses showed that the system was able to efficiently inhibit autophagy of HCC cells and tissue in a tissue-specific manner. Further in vivo metastasis assay showed that intratumoral administration of the system could significantly suppress lung metastasis. Together, our findings suggest that autophagy may be involved in HCC metastasis through facilitating anoikis resistance and lung colonization of HCC cells. Autophagy-based HCC tissue-specific target therapy may be a new strategy for the management of HCC metastasis.

MicroRNA-30a Suppresses Autophagy-Mediated Anoikis Resistance and Metastasis in Hepatocellular Carcinoma.

miR-30 functions as a tumor suppressor by modulating CD90 in hepatocellular carcinoma

MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.

Regulation of Autophagy by a Beclin 1-Targeted Microrna, Mir-30A, in Cancer Cells

MicroRNA-449a Suppresses Hepatocellular Carcinoma Cell Growth Via G1 Phase Arrest and the HGF/MET C-Met Pathway

Retraction Note: MicroRNA-1468 Promotes Tumor Progression by Activating PPAR-γ-mediated AKT Signaling in Human Hepatocellular Carcinoma

MicroRNA-145 Suppresses Hepatocellular Carcinoma by Targeting IRS1 and Its Downstream Akt Signaling.

MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells

Autophagy Inhibition Suppresses Pulmonary Metastasis of HCC in Mice Via Impairing Anoikis Resistance and Colonization of HCC Cells.

Mir-30D Regulates Multiple Genes in the Autophagy Pathway and Impairs Autophagy Process in Human Cancer Cells

MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications

Microrna-30a Sensitizes Tumor Cells to Cis-Platinum Via Suppressing Beclin 1-Mediated Autophagy

Cross-regulation Between Micrornas and Key Proteins of Signaling Pathways in Hepatocellular Carcinoma

MicroRNA-302a enhances 5-fluorouracil sensitivity in HepG2 cells by increasing AKT/ULK1-dependent autophagy-mediated apoptosis

MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib

Targeting STK26 and ATG4B: Mir-22-3p As a Modulator of Autophagy and Tumor Progression in HCC

MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin

Mir-17-5p and Mir-20A-5p Suppress Postoperative Metastasis of Hepatocellular Carcinoma Via Blocking HGF/ERBB3-NF-κB Positive Feedback Loop

MiR-26 Enhances Chemosensitivity and Promotes Apoptosis of Hepatocellular Carcinoma Cells Through Inhibiting Autophagy

Clinicopathological Role of Mir-30A-5p in Hepatocellular Carcinoma Tissues and Prediction of Its Function with Bioinformatics Analysis

MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.